Navigation Links
NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
Date:7/18/2011

LOS ANGELES, July 18, 2011 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, today announced the formation of a majority owned subsidiary, NSVascular, Inc. and the signing of an exclusive license with the University of California, Los Angeles (UCLA) covering its medical applications of Thin-Film Nitinol (TFN) technology.  Nitinol is a superelastic nickel and titanium alloy with unique properties that allow deformation and subsequent full recovery of the original shape upon exposure to body heat.

NSVascular will focus on developing and commercializing TFN-covered stents for endovascular applications, with its first two applications being flow-diverting stents for intracranial aneurysms (IA) and stents for treating peripheral artery disease (PAD).

A multidisciplinary team, comprised of researchers from the UCLA Henry Samueli School of Engineering and Applied Science in collaboration with physicians from the David Geffen School of Medicine at UCLA, has been engaged in the development and the in vitro/in vivo testing of TFN-covered IA and PAD stents.   "For the past five years our engineering team has benefited from collaborating with a top-notch UCLA medical team, spearheaded by Dr. Dan Levi and Dr. Fernando Vinuela.  I am looking forward to working closely with the experienced management team at NeuroSigma and NSVascular in commercializing this promising technology," said Greg Carman, Ph.D., UCLA Professor of Mechanical and Aerospace Engineering and a co-founder of NSVascular.

"We are very excited that NSVascular will be moving this technology through translational studies and hopefully ultimately to patients thereby benefitting both society and the economy at large," said Earl Weinstein, Associate Director of UCLA's Office of Intellectual Property.

"We are delighted to have signed our fourth license with UCLA's Office of Intellectual Property and look forward to working closely
'/>"/>

SOURCE NeuroSigma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
2. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
3. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
4. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
5. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
6. Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiarys Stock to Investors
7. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
8. NeoMatrix, Inc., Awarded New Technology Agreement by Novation for HALO(R) Breast Pap Test
9. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
10. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
11. OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its ION free Large Diameter Head Dual Mobility Acetabular Cup System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  Building on the momentum of the ... provider of medical alert systems, has announced aggressive plans to ... program and Managed Care business models. The first ... , Tennessee and Louisiana ... regional contracts to span statewide coverage in each state. This ...
(Date:3/30/2015)... & Long, P.A.: , Do you own shares ... , Did you purchase any of your shares prior to ... buyout price is too low? , Do you want ... Long, P.A. announces that it is investigating potential legal ... ("Auspex" or the "Company") (NASDAQ GM: ASPX ) regarding ...
(Date:3/30/2015)... BOSTON , March 30, 2015  MedAptus® ... newest solution designed to simplify pre-care needs for ... rules-based intelligence to automatically assign patients to hospitalists ... continuity of care and other requirements such as ... efficiency. ...
Breaking Medicine Technology:MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3
(Date:3/30/2015)... 2015 A key protein previously implicated ... an important role in the response to viral infection, ... Icahn School of Medicine at Mount Sinai published today ... been associated with inflammation, part of the body’s response ... home in to attack invaders like bacteria and viruses, ...
(Date:3/30/2015)... 30, 2015 Vancouver personal injury lawyer ... majority of cases taken up by the firm are ... the lawyers help protect the interests of their clients ... process. The announcement comes across as an achievement for ... to provide convenience to their client, without compromising their ...
(Date:3/30/2015)... Follow us on LinkedIn – ... establish chronic pain rehabilitation centers are driving demand for ... poised to benefit from the rise in acute and ... chronic health conditions such as Cancer, degenerative diseases, osteoarthritis, ... conventional treatment for pain management is dominated by opioid ...
(Date:3/30/2015)... 2015 On March 19th, 2015, in ... of the Detroit Lions, LiveToBeSober.org hosted the “Fighting Addiction ... ministers and bishops as well as other civic leaders ... at the luncheon, including retired Detroit Lions wide receiver ... and two survivors of their own personal battles with ...
(Date:3/30/2015)... 2015 Dr. Daniel Shapiro, one of the ... recently featured on Phoenix’s Channel 12 News about the benefits ... minimally invasive alternative to facelifts developed by Dr. Shapiro. , ... at Shapiro Aesthetic Plastic Surgery and Skin Klinic worked closely ... news story on GenXLift. The story detailed the experience and ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2
... Association (APTA) is pointing to a new study on low ... the newly established Center for Medicare and Medicaid Innovation to ... therapist services that was recommended in the recent health reform ... , showed Medicare patients who received physical therapy in the ...
... News) -- Women who experience restless legs syndrome (RLS) ... again during future pregnancies or developing a chronic form ... RLS causes unpleasant sensations in the legs. Symptoms ... with age. Movement generally relieves symptoms. Italian researchers ...
... integrin: a protein predictor of tumor spread? ... Center, Nashville, have generated data that lead them to ... is predictive of tumor dissemination to distant sites and ... cancer. The researchers first studied the role of ...
... -- An expansion of soybean production into areas where ... problematic for some farmers. Soils having high pH values ... notoriously iron deficient. Iron deficient soils in the North ... production by 12.5 million bushels every year., John Wiersma, ...
... past decade, significant advances have been made in the ... targeted therapies. Research that will be presented today at ... Hematology provides greater understanding of the optimal use of ... leukemia (ALL) and chronic myeloid leukemia (CML), and how ...
... combined with daily medication to remove the resulting excess ... of recurrent strokes in young patients with sickle cell ... trial that includes St. Jude Children,s Research Hospital. ... the potentially life-threatening problem of iron overload caused by ...
Cached Medicine News:Health News:Early physical therapy for low back pain associated with less subsequent health care utilization 2Health News:Restless Legs in Pregnancy Likely to Recur, Researchers Say 2Health News:JCI online early table of contents: Dec. 6, 2010 2Health News:JCI online early table of contents: Dec. 6, 2010 3Health News:JCI online early table of contents: Dec. 6, 2010 4Health News:JCI online early table of contents: Dec. 6, 2010 5Health News:JCI online early table of contents: Dec. 6, 2010 6Health News:JCI online early table of contents: Dec. 6, 2010 7Health News:JCI online early table of contents: Dec. 6, 2010 8Health News:Iron deficiency in soil threatens soybean production 2Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 2Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 3Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 4Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 5Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 6Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 7Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 8Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 9Health News:New therapies and gene target advance the treatment and understanding of hard-to-treat leukemias 10Health News:2 studies provide insight into stroke risk and prevention in young sickle cell anemia patients 2Health News:2 studies provide insight into stroke risk and prevention in young sickle cell anemia patients 3
... TowerPack is an innovative, quick and ... Tips. Use 60% less space on ... plastic. With this amazingly easy-to-use, one-hand ... for the whole range of Diamond ...
... wide orifice tip, the Finntip Wide is ... and macromolecules like genomic DNA. This tip ... fragmentation. It is excellent for use with ... the inside diameter of the orifice is ...
... have been designed to optimize the accuracy ... our tip products is widely recognized by ... has been extended over the years and ... and special tips including filter tips, certified ...
RNase-free Tips...
Medicine Products: